Activity Overview
This educational activity is an archive of the live conference held from February 26, 2026, through February 28, 2026.
Target Audience
This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
Upon participation in this activity, learners will be better able to:
- Evaluate recent clinical trial results on approved and emerging therapeutic approaches for patients with hematologic disorders
- Describe best practices for mitigating and managing treatment-related adverse events in patients with hematologic disorders
André H. Goy, MD
Vice President Physician in Chief Oncology
Chairman & Chief Physician Officer - John
Theurer Cancer Center
Lydia Pfund Chair for Lymphoma
Academic Chairman Oncology- Hackensack
Meridian School of Medicine
Professor of Medicine – Georgetown University
Hackensack, NJ
Lorenzo Falchi, MD
Assistant Attending Physician
Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine
Weill Cornell Medical College
New York, NY
Nicole Lamanna, MD
Judy Horrigan Professor of Medicine
Director, Chronic Lymphocytic Leukemia
Program
Chief, Leukemia Service
Herbert Irving Comprehensive Cancer Center
NewYork-Presbyterian/Columbia University
Medical Center
New York, NY
Lori A. Leslie, MD
Associate Professor of Medicine
Hackensack Meridian School of Medicine
Attending Physician, Lymphoma Division
Director, Indolent Lymphoma and CLL Research
Programs
John Theurer Cancer Center
Hackensack, NJ
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here